Morgan Stanley analyst Michael Ulz reiterated a Buy rating on Kyverna Therapeutics, Inc. (KYTX – Research Report) yesterday and set a price ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...